Posted On: 04/18/2016 9:56:53 AM
Post# of 1525
NEW YORK, NY / ACCESSWIRE / April 18, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage on Progressive Care, Inc. (RXMD) with a price target of $0.10.
The report is available here: RXMD Initiation Report. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's. The report will be available on these platforms. The firm also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.
http://finance.yahoo.com/news/seethruequity-i...00802.html
The report is available here: RXMD Initiation Report. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's. The report will be available on these platforms. The firm also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.
http://finance.yahoo.com/news/seethruequity-i...00802.html
(1)
(0)
